The use of transvaginal sonography and vaginoscopic hysteroscopy in women on tamoxifen.

Autor:	Paschopoulos M; Department of Obstetrics & Gynecology, Ioannina University Hospital, Greece. paschomi@acropolis.net, Kontostolis E, Lolis ED, Koliopoulos G, Alamanos Y, Paraskevaidis E
Jazyk:	angličtina
Zdroj:	JSLS : Journal of the Society of Laparoendoscopic Surgeons [JSLS] 2001 Jul-Sep; Vol. 5 (3), pp. 211-4.
Abstrakt:	Background and Objectives: Long-term administration of tamoxifen causes endometrial changes. The aim of this study was to evaluate the role of transvaginal sonography and vaginoscopic hysteroscopy in the screening of patients on tamoxifen. Methods: Seventy patients with breast cancer treated with tamoxifen 20 mg daily underwent transvaginal sonography and vaginoscopic hysteroscopy, a modified relatively painless approach, at the beginning of the treatment and at a follow-up visit approximately 9 months after its initiation. Results: At the follow-up visit, the mean uterine dimensions and mean endometrial thickness as measured by ultrasound were significantly larger, and pulsatility and resistance indices of the uterine arteries as measured by Doppler were significantly lower. Sonography revealed abnormal endometrial thickness in 73% (51 of 70) of the patients, and 83% (58 of 70) had hysteroscopical changes. Sonography missed 1 case of endometrial adenocarcinoma. Conclusions: Vaginoscopic hysteroscopy, an approach that causes reduced pain, can add significantly to the sensitivity of transvaginal sonography for the detection of endometrial changes in patients with breast cancer receiving tamoxifen. It is recommended for every patient prior to the initiation of treatment and at the follow-up visits.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu